{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:59:17Z","timestamp":1773500357234,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1188\/21"],"award-info":[{"award-number":["1188\/21"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1906\/21"],"award-info":[{"award-number":["1906\/21"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1086\/17"],"award-info":[{"award-number":["1086\/17"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003975","name":"Israel Cancer Association","doi-asserted-by":"publisher","award":["00"],"award-info":[{"award-number":["00"]}],"id":[{"id":"10.13039\/501100003975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003975","name":"Israel Cancer Association","doi-asserted-by":"publisher","award":["00"],"award-info":[{"award-number":["00"]}],"id":[{"id":"10.13039\/501100003975","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gassner Fund for Medical Research, Emerson Collective Cancer Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Colon carcinoma is among the most prevalent malignant tumors, with inflammation being the primary risk factor. Cannabinoid receptor 2 (CB2\/CNR2) has complex immunomodulatory functions. Therefore, we investigated the role of osteogenic growth peptide (OGP), an endogenous selective CB2 agonist, in colon carcinogenesis and immune modulation in transgenic mice (Apc<jats:sup>Min\/+<\/jats:sup>).We injected 8-week-old (progression phase) or five-week-old (initiation phase) Apc<jats:sup>Min\/+<\/jats:sup> mice with OGP or vehicle weekly for 8 weeks or 4 weeks, respectively. During the progression phase, OGP-treated mice displayed significantly fewer tumors in the large intestine and smaller tumors in the small intestine. During the initiation phase, OGP significantly attenuated adenomagenesis in both the small and large intestine, decreased IL-6 and IL-4 levels, increased splenic anti-tumor CD8+ T cells, and diminished populations of tumor-promoting myeloid-derived suppressor cells. Further, we used exomic analyses of UKBiobank patients to determine the relationship between <jats:italic>CNR2<\/jats:italic> polymorphisms and tumor-associated myeloid cells in humans. We found that the common CNR2-Q63R polymorphism is associated with monocyte count. Our results suggest that CB2 activation via OGP attenuates tumorigenesis and adenoma growth by modulating immune cells, corroborated by a significant association between <jats:italic>CNR2<\/jats:italic> polymorphisms and monocytopoiesis in humans.<\/jats:p>","DOI":"10.1038\/s41388-025-03399-9","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:03:20Z","timestamp":1746065000000},"page":"2504-2514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunomodulatory function of cannabinoid receptor 2 and its agonist osteogenic growth peptide in health and cancer: a study in mice and humans"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5721-4348","authenticated-orcid":false,"given":"Jennifer Ana","family":"Iden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Ben-Califa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Naim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Liron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drorit","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7494-0631","authenticated-orcid":false,"given":"Yankel","family":"Gabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"3399_CR1","first-page":"145","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145\u201364.","journal-title":"CA Cancer J Clin"},{"key":"3399_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.coph.2009.06.006","volume":"9","author":"S Kraus","year":"2009","unstructured":"Kraus S, Arber N. Inflammation and colorectal cancer. Curr Opin Pharmacol. 2009;9:405\u201310.","journal-title":"Curr Opin Pharmacol"},{"key":"3399_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd1495","volume":"3","author":"VD Marzo","year":"2004","unstructured":"Marzo VD, Bifulco M, Petrocellis LD. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov. 2004;3:771\u201384.","journal-title":"Nat Rev Drug Discov"},{"key":"3399_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/03602532.2018.1428344","volume":"50","author":"R Schwarz","year":"2018","unstructured":"Schwarz R, Ramer R, Hinz B. Targeting the endocannabinoid system as a potential anticancer approach. Drug Metab Rev. 2018;50:26\u201353.","journal-title":"Drug Metab Rev"},{"key":"3399_CR5","doi-asserted-by":"publisher","first-page":"1296906","DOI":"10.3389\/fonc.2023.1296906","volume":"13","author":"A Sarsembayeva","year":"2023","unstructured":"Sarsembayeva A, Schicho R. Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?. Front Oncol. 2023;13:1296906.","journal-title":"Front Oncol"},{"key":"3399_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","volume":"153","author":"J Guindon","year":"2008","unstructured":"Guindon J, Hohmann A. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol. 2008;153:319\u201334.","journal-title":"Br J Pharmacol"},{"key":"3399_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1517\/14728222.10.5.653","volume":"10","author":"CA Lunn","year":"2006","unstructured":"Lunn CA, Reich E-P, Bober L. Targeting the CB2 receptor for immune modulation. Expert Opin Ther Targets. 2006;10:653\u201363.","journal-title":"Expert Opin Ther Targets"},{"key":"3399_CR8","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.3390\/ijms24044060","volume":"24","author":"JA Iden","year":"2023","unstructured":"Iden JA, Raphael-Mizrahi B, Awida Z, Naim A, Zyc D, Liron T, et al. The anti-tumorigenic role of cannabinoid receptor 2 in colon cancer: a study in mice and humans. Int J Mol Sci. 2023;24:4060.","journal-title":"Int J Mol Sci"},{"key":"3399_CR9","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.3390\/ijms24097773","volume":"24","author":"JA Iden","year":"2023","unstructured":"Iden JA, Raphael-Mizrahi B, Naim A, Kolomansky A, Liron T, Neumann D, et al. The anti-tumorigenic role of cannabinoid receptor 2 in non-melanoma skin cancer. Int J Mol Sci. 2023;24:7773.","journal-title":"Int J Mol Sci"},{"key":"3399_CR10","doi-asserted-by":"publisher","first-page":"e65834","DOI":"10.7554\/eLife.65834","volume":"11","author":"B Raphael-Mizrahi","year":"2022","unstructured":"Raphael-Mizrahi B, Attar-Namdar M, Chourasia M, Cascio MG, Shurki A, Tam J, et al. Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2. Elife. 2022;11:e65834.","journal-title":"Elife"},{"key":"3399_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/ijms17111885","volume":"17","author":"SC Pigossi","year":"2016","unstructured":"Pigossi SC, Medeiros MC, Saska S, Cirelli JA, Scarel-Caminaga RM. Role of osteogenic growth peptide (OGP) and OGP (10\u201314) in bone regeneration: a review. Int J Mol Sci. 2016;17:1885.","journal-title":"Int J Mol Sci"},{"key":"3399_CR12","doi-asserted-by":"publisher","first-page":"2202058","DOI":"10.1002\/advs.202202058","volume":"9","author":"T Zhang","year":"2022","unstructured":"Zhang T, Zhou M, Xiao D, Liu Z, Jiang Y, Feng M, et al. Myelosuppression alleviation and hematopoietic regeneration by tetrahedral-framework nucleic-acid nanostructures functionalized with osteogenic growth peptide. Adv Sci. 2022;9:2202058.","journal-title":"Adv Sci"},{"key":"3399_CR13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.yexcr.2018.07.035","volume":"370","author":"P Xu","year":"2018","unstructured":"Xu P, He H, Gu Y, Wang Y, Sun Z, Yang L, et al. Surgical trauma contributes to progression of colon cancer by downregulating CXCL4 and recruiting MDSCs. Exp Cell Res. 2018;370:692\u20138.","journal-title":"Exp Cell Res"},{"key":"3399_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neo.2017.04.006","volume":"19","author":"A Jayakumar","year":"2017","unstructured":"Jayakumar A, Bothwell AL. Stat6 promotes intestinal tumorigenesis in a mouse model of adenomatous polyposis by expansion of MDSCs and inhibition of cytotoxic CD8 response. Neoplasia. 2017;19:595\u2013605.","journal-title":"Neoplasia"},{"key":"3399_CR15","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.18632\/oncotarget.12278","volume":"8","author":"CR Millrud","year":"2017","unstructured":"Millrud CR, Bergenfelz C, Leandersson K. On the origin of myeloid-derived suppressor cells. Oncotarget. 2017;8:3649.","journal-title":"Oncotarget"},{"key":"3399_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","volume":"120","author":"C Groth","year":"2019","unstructured":"Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer. 2019;120:16\u201325.","journal-title":"Br J Cancer"},{"key":"3399_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.humimm.2016.12.001","volume":"78","author":"J Chen","year":"2017","unstructured":"Chen J, Ye Y, Liu P, Yu W, Wei F, Li H, et al. Suppression of T cells by myeloid-derived suppressor cells in cancer. Hum Immunol. 2017;78:113\u20139.","journal-title":"Hum Immunol"},{"key":"3399_CR18","doi-asserted-by":"publisher","first-page":"6562","DOI":"10.4049\/jimmunol.0803831","volume":"182","author":"S Mandruzzato","year":"2009","unstructured":"Mandruzzato S, Solito S, Falisi E, Francescato S, Chiarion-Sileni V, Mocellin S, et al. IL4R\u03b1+ myeloid-derived suppressor cell expansion in cancer patients. J Immunol. 2009;182:6562\u20138.","journal-title":"J Immunol"},{"key":"3399_CR19","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/eji.201142230","volume":"42","author":"P Sinha","year":"2012","unstructured":"Sinha P, Parker KH, Horn L, Ostrand-Rosenberg S. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-\u03b3 and IL-4 R \u03b1. European J Immunol. 2012;42:2052\u20139.","journal-title":"European J Immunol"},{"key":"3399_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104254","volume":"359","author":"R Weber","year":"2021","unstructured":"Weber R, Groth C, Lasser S, Arkhypov I, Petrova V, Altevogt P, et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cell Immunol. 2021;359:104254.","journal-title":"Cell Immunol"},{"key":"3399_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/membranes11050312","volume":"11","author":"M Turano","year":"2021","unstructured":"Turano M, Cammarota F, Duraturo F, Izzo P, De Rosa M. A potential role of IL-6\/IL-6R in the development and management of colon cancer. Membranes. 2021;11:312.","journal-title":"Membranes"},{"key":"3399_CR22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/hep.26705","volume":"59","author":"T Zheng","year":"2014","unstructured":"Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, et al. Gankyrin promotes tumor growth and metastasis through activation of IL-6\/STAT3 signaling in human cholangiocarcinoma. Hepatology. 2014;59:935\u201346.","journal-title":"Hepatology"},{"key":"3399_CR23","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/carcin\/bgq044","volume":"31","author":"FL Koller","year":"2010","unstructured":"Koller FL, Hwang DG, Dozier E, Fingleton B. Epithelial interleukin-4 receptor expression promotes colon tumor growth. Carcinogenesis. 2010;31:1010\u20137.","journal-title":"Carcinogenesis"},{"key":"3399_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101504","volume":"23","author":"W Becker","year":"2020","unstructured":"Becker W, Alrafas HR, Wilson K, Miranda K, Culpepper C, Chatzistamou I, et al. Activation of cannabinoid receptor 2 prevents colitis-associated colon cancer through myeloid cell de-activation upstream of IL-22 production. Iscience. 2020;23:101504.","journal-title":"Iscience"},{"key":"3399_CR25","doi-asserted-by":"publisher","first-page":"e001643","DOI":"10.1136\/jitc-2020-001643","volume":"9","author":"MA Ghonim","year":"2021","unstructured":"Ghonim MA, Ibba SV, Tarhuni AF, Errami Y, Luu HH, Dean MJ, et al. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. J Immunother Cancer. 2021;9:e001643.","journal-title":"J Immunother Cancer"},{"key":"3399_CR26","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1002\/ijc.33477","volume":"148","author":"VR Jala","year":"2021","unstructured":"Jala VR, Bodduluri SR, Ghosh S, Chheda Z, Singh R, Smith ME, et al. Absence of CCR2 reduces spontaneous intestinal tumorigenesis in the ApcMin\/+ mouse model. Int J Cancer. 2021;148:2594\u2013607.","journal-title":"Int J Cancer"},{"key":"3399_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn0175","volume":"7","author":"E Jou","year":"2022","unstructured":"Jou E, Rodriguez-Rodriguez N, Ferreira A-CF, Jolin HE, Clark PA, Sawmynaden K, et al. An innate IL-25\u2013ILC2\u2013MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis. Sci Immunol. 2022;7:eabn0175.","journal-title":"Sci Immunol"},{"key":"3399_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/0959-8049(95)00181-H","volume":"31","author":"A Moser","year":"1995","unstructured":"Moser A, Luongo C, Gould KA, McNeley M, Shoemaker A, Dove W. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer. 1995;31:1061\u20134.","journal-title":"Eur J Cancer"},{"key":"3399_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00432-019-02883-6","volume":"145","author":"J Ren","year":"2019","unstructured":"Ren J, Sui H, Fang F, Li Q, Li B. The application of Apc Min\/+ mouse model in colorectal tumor researches. J Cancer Res Clin Oncol. 2019;145:1111\u201322.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3399_CR30","first-page":"3481","volume":"115","author":"J Wang","year":"2010","unstructured":"Wang J, Fernald AA, Anastasi J, Le Beau MM, Qian Z. Haploinsufficiency of Apc leads to ineffective hematopoiesis. Blood, J Am Soc Hematol. 2010;115:3481\u20138.","journal-title":"Blood, J Am Soc Hematol"},{"key":"3399_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1349-7006.2006.00348.x","volume":"98","author":"Y Yamada","year":"2007","unstructured":"Yamada Y, Mori H. Multistep carcinogenesis of the colon in ApcMin\/+ mouse. Cancer Sci. 2007;98:6\u201310.","journal-title":"Cancer Sci"},{"key":"3399_CR32","first-page":"5136","volume":"63","author":"HL Kettunen","year":"2003","unstructured":"Kettunen HL, Kettunen AS, Rautonen NE. Intestinal immune responses in wild-type and Apc min\/+ mouse, a model for colon cancer. Cancer Res. 2003;63:5136\u201342.","journal-title":"Cancer Res"},{"key":"3399_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00439-009-0708-8","volume":"126","author":"M Karsak","year":"2009","unstructured":"Karsak M, Malkin I, Toliat MR, Kubisch C, N\u00fcrnberg P, Zimmer A, et al. The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample. Human Genet. 2009;126:629\u201336.","journal-title":"Human Genet"},{"key":"3399_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/GME.0000000000000339","volume":"22","author":"JH Woo","year":"2015","unstructured":"Woo JH, Kim H, Kim JH, Kim JG. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women. Menopause. 2015;22:512\u20139.","journal-title":"Menopause"},{"key":"3399_CR35","doi-asserted-by":"publisher","first-page":"e0279356","DOI":"10.1371\/journal.pone.0279356","volume":"18","author":"D S\u0142omian","year":"2023","unstructured":"S\u0142omian D, Szyda J, Dobosz P, Stojak J, Michalska-Foryszewska A, Sypniewski M, et al. Better safe than sorry\u2014whole-genome sequencing indicates that missense variants are significant in susceptibility to COVID-19. PLoS ONE. 2023;18:e0279356.","journal-title":"PLoS ONE"},{"key":"3399_CR36","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/hmg\/ddi370","volume":"14","author":"M Karsak","year":"2005","unstructured":"Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, Kornak U, et al. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Human Mol Genet. 2005;14:3389\u201396.","journal-title":"Human Mol Genet"},{"key":"3399_CR37","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1007\/s00198-015-3195-x","volume":"26","author":"C Zhang","year":"2015","unstructured":"Zhang C, Ma J, Chen G, Fu D, Li L, Li M. Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese. Osteoporosis Int. 2015;26:2803\u201310.","journal-title":"Osteoporosis Int"},{"key":"3399_CR38","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","volume":"167","author":"WJ Astle","year":"2016","unstructured":"Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167:1415\u201329:e1419.","journal-title":"Cell"},{"key":"3399_CR39","doi-asserted-by":"publisher","first-page":"862255","DOI":"10.3389\/fimmu.2022.862255","volume":"13","author":"J H\u00f6glund","year":"2022","unstructured":"H\u00f6glund J, Hadizadeh F, Ek WE, Karlsson T, Johansson \u00c5. Gene-based variant analysis of whole-exome sequencing in relation to eosinophil count. Frontiers Immunol. 2022;13:862255.","journal-title":"Frontiers Immunol"},{"key":"3399_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/FPC.0b013e3283367c6b","volume":"20","author":"A Carrasquer","year":"2010","unstructured":"Carrasquer A, Nebane NM, Williams WM, Song Z-H. Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor. Pharmacogenetics Genomics. 2010;20:157\u201366.","journal-title":"Pharmacogenetics Genomics"},{"key":"3399_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1189\/jlb.0205111","volume":"78","author":"JC Sipe","year":"2005","unstructured":"Sipe JC, Arbour N, Gerber A, Beutler E. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol. 2005;78:231\u20138.","journal-title":"J Leukoc Biol"},{"key":"3399_CR42","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s10067-018-4217-9","volume":"37","author":"M Ismail","year":"2018","unstructured":"Ismail M, Khawaja G. Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis. Clinical Rheumatol. 2018;37:2933\u20138.","journal-title":"Clinical Rheumatol"},{"key":"3399_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/03009742.2015.1020863","volume":"44","author":"G Bellini","year":"2015","unstructured":"Bellini G, Olivieri AN, Grandone A, Alessio M, Gicchino M, Nobili B, et al. Association between cannabinoid receptor type 2 Q63R variant and oligo\/polyarticular juvenile idiopathic arthritis. Scand J Rheumatol. 2015;44:284\u20137.","journal-title":"Scand J Rheumatol"},{"key":"3399_CR44","doi-asserted-by":"publisher","first-page":"e42259","DOI":"10.1371\/journal.pone.0042259","volume":"7","author":"F Rossi","year":"2012","unstructured":"Rossi F, Bellini G, Alisi A, Alterio A, Maione S, Perrone L, et al. Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease. PLoS One. 2012;7:e42259.","journal-title":"PLoS One"},{"key":"3399_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phrs.2012.03.011","volume":"66","author":"F Rossi","year":"2012","unstructured":"Rossi F, Bellini G, Tolone C, Luongo L, Mancusi S, Papparella A, et al. The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. Pharmacol Res. 2012;66:88\u201394.","journal-title":"Pharmacol Res"},{"key":"3399_CR46","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3324\/haematol.2011.045732","volume":"96","author":"F Rossi","year":"2011","unstructured":"Rossi F, Mancusi S, Bellini G, Roberti D, Punzo F, Vetrella S, et al. CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. Haematologica. 2011;96:1883.","journal-title":"Haematologica"},{"key":"3399_CR47","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/MCG.0000000000000755","volume":"52","author":"C Strisciuglio","year":"2018","unstructured":"Strisciuglio C, Bellini G, Miele E, Martinelli M, Cenni S, Tortora C, et al. Cannabinoid receptor 2 functional variant contributes to the risk for pediatric inflammatory bowel disease. J Clin Gastroenterol. 2018;52:e37\u2013e43.","journal-title":"J Clin Gastroenterol"},{"key":"3399_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31701-w","volume":"13","author":"W Osman","year":"2023","unstructured":"Osman W, Mousa M, Albreiki M, Baalfaqih Z, Daggag H, Hill C, et al. A genome-wide association study identifies a possible role for cannabinoid signalling in the pathogenesis of diabetic kidney disease. Sci Rep. 2023;13:4661.","journal-title":"Sci Rep"},{"key":"3399_CR49","doi-asserted-by":"publisher","first-page":"12369","DOI":"10.18632\/oncotarget.3682","volume":"6","author":"I Dufait","year":"2015","unstructured":"Dufait I, Schwarze JK, Liechtenstein T, Leonard W, Jiang H, Escors D, et al. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer. Oncotarget. 2015;6:12369.","journal-title":"Oncotarget"},{"key":"3399_CR50","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/cells12131704","volume":"12","author":"F Pegka","year":"2023","unstructured":"Pegka F, Ben-Califa N, Neumann D, J\u00e4kel H, Hengst L. EpoR activation stimulates erythroid precursor proliferation by inducing phosphorylation of tyrosine-88 of the CDK-inhibitor p27Kip1. Cells. 2023;12:1704.","journal-title":"Cells"},{"key":"3399_CR51","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman JD, Li AH, Marcketta A, Sun D, Mbatchou J, Kessler MD, et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021;599:628\u201334.","journal-title":"Nature"},{"key":"3399_CR52","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41588-021-00892-1","volume":"53","author":"AR Barton","year":"2021","unstructured":"Barton AR, Sherman MA, Mukamel RE, Loh P-R. Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses. Nature Genet. 2021;53:1260\u20139.","journal-title":"Nature Genet"},{"key":"3399_CR53","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","volume":"31","author":"MJ Machiela","year":"2015","unstructured":"Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555\u20137.","journal-title":"Bioinformatics"},{"key":"3399_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.sjbs.2016.09.002","volume":"24","author":"J Xie","year":"2017","unstructured":"Xie J, Zhang J, Wu H, Tang X, Liu J, Cheng G, et al. The influences of age on T lymphocyte subsets in C57BL\/6 mice. Saudi J Biol Sci. 2017;24:108\u201313.","journal-title":"Saudi J Biol Sci"},{"key":"3399_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/cmi.2011.47","volume":"9","author":"E Zhao","year":"2012","unstructured":"Zhao E, Xu H, Wang L, Kryczek I, Wu K, Hu Y, et al. Bone marrow and the control of immunity. Cell Mol Immunol. 2012;9:11\u201319.","journal-title":"Cell Mol Immunol"},{"key":"3399_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-13-69","volume":"13","author":"E K\u00e4llberg","year":"2012","unstructured":"K\u00e4llberg E, Stenstr\u00f6m M, Liberg D, Ivars F, Leanderson T. CD11b+ Ly6C++ Ly6G-cells show distinct function in mice with chronic inflammation or tumor burden. BMC Immunol. 2012;13:1\u201310.","journal-title":"BMC Immunol"},{"key":"3399_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4933-5-1","volume":"5","author":"LM Pinchuk","year":"2008","unstructured":"Pinchuk LM, Filipov NM. Differential effects of age on circulating and splenic leukocyte populations in C57BL\/6 and BALB\/c male mice. Immunity ageing. 2008;5:1\u201312.","journal-title":"Immunity ageing"},{"key":"3399_CR58","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1055\/s-0037-1602237","volume":"31","author":"RW Stidham","year":"2018","unstructured":"Stidham RW, Higgins PD. Colorectal cancer in inflammatory bowel disease. Clinics colon rectal Surg. 2018;31:168\u201378.","journal-title":"Clinics colon rectal Surg"},{"key":"3399_CR59","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/j.gastro.2008.04.039","volume":"135","author":"P Maisonneuve","year":"2008","unstructured":"Maisonneuve P, Botteri E, Lowenfels AB. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology. 2008;135:710.","journal-title":"Gastroenterology"},{"key":"3399_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2144\/btn-2018-0017","volume":"65","author":"A-M Park","year":"2018","unstructured":"Park A-M, Tsunoda I. Forensic luminol reaction for detecting fecal occult blood in experimental mice. Biotechniques. 2018;65:227\u201330.","journal-title":"Biotechniques"},{"key":"3399_CR61","doi-asserted-by":"publisher","first-page":"1343061","DOI":"10.3389\/fonc.2024.1343061","volume":"14","author":"CO Kelson","year":"2024","unstructured":"Kelson CO, Zaytseva YY. Altered lipid metabolism in APC-driven colorectal cancer: the potential for therapeutic intervention. Frontiers Oncol. 2024;14:1343061.","journal-title":"Frontiers Oncol"},{"key":"3399_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.21873\/cdp.10196","volume":"3","author":"L Chardalias","year":"2023","unstructured":"Chardalias L, Papaconstantinou I, Gklavas A, Politou M, Theodosopoulos T. Iron deficiency anemia in colorectal cancer patients: is preoperative intravenous iron infusion indicated? A narrative review of the literature. Cancer Diagn Progn. 2023;3:163\u20138.","journal-title":"Cancer Diagn Progn"},{"key":"3399_CR63","first-page":"463","volume":"65","author":"Z-J Liu","year":"2005","unstructured":"Liu Z-J, You S, Hrushesky WJM, Wood PA, Wyatt MD, Berger SH. Possible role of APC gene in hematopoisis: an implication from anemia in ApcMIN\/+ mice. Cancer Res. 2005;65:463\u2013463.","journal-title":"Cancer Res"},{"key":"3399_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.exphem.2019.09.022","volume":"78","author":"E Danner","year":"2019","unstructured":"Danner E, Hoffmann F, Lee S-Y, Cordes F, Orban S, Dauber K, et al. Modest and nonessential roles of the endocannabinoid system in immature hematopoiesis of mice. Exp Hematol. 2019;78:35\u201345.","journal-title":"Exp Hematol"},{"key":"3399_CR65","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2010-01-265082","volume":"117","author":"S Jiang","year":"2011","unstructured":"Jiang S, Alberich-Jorda M, Zagozdzon R, Parmar K, Fu Y, Mauch P, et al. Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood. 2011;117:827\u201338.","journal-title":"Blood"},{"key":"3399_CR66","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/cam4.842","volume":"5","author":"A Hodgson","year":"2016","unstructured":"Hodgson A, Wier EM, Fu K, Sun X, Wan F. Ultrasound imaging of splenomegaly as a proxy to monitor colon tumor development in Apcmin716\/+ mice. Cancer Med. 2016;5:2469\u201376.","journal-title":"Cancer Med"},{"key":"3399_CR67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.humpath.2017.09.012","volume":"69","author":"K Wang","year":"2017","unstructured":"Wang K, Shen T, Siegal GP, Wei S. The CD4\/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Human Pathol. 2017;69:110\u20137.","journal-title":"Human Pathol"},{"key":"3399_CR68","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1182\/blood-2009-12-258756","volume":"115","author":"C B\u00f6iers","year":"2010","unstructured":"B\u00f6iers C, Buza-Vidas N, Jensen CT, Pronk CJ, Kharazi S, Wittmann L, et al. Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development. Blood. 2010;115:5061\u20138.","journal-title":"Blood"},{"key":"3399_CR69","doi-asserted-by":"publisher","first-page":"a021857","DOI":"10.1101\/cshperspect.a021857","volume":"6","author":"ER Stanley","year":"2014","unstructured":"Stanley ER, Chitu V. CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol. 2014;6:a021857.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3399_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich DI. Myeloid-derived suppressor cells. Cancer Immunol Res. 2017;5:3\u20138.","journal-title":"Cancer Immunol Res"},{"key":"3399_CR71","first-page":"33","volume":"66","author":"I Bab","year":"2002","unstructured":"Bab I, Chorev M. Osteogenic growth peptide: from concept to drug design. Peptide Sci Original Res Biomol. 2002;66:33\u201348.","journal-title":"Peptide Sci Original Res Biomol"},{"key":"3399_CR72","doi-asserted-by":"publisher","first-page":"14883","DOI":"10.1021\/bi971670t","volume":"36","author":"H Gavish","year":"1997","unstructured":"Gavish H, Bab I, Tartakovsky A, Chorev M, Mansur N, Greenberg Z, et al. Human \u03b12-macroglobulin is an osteogenic growth peptide-binding protein. Biochemistry. 1997;36:14883\u20138.","journal-title":"Biochemistry"},{"key":"3399_CR73","doi-asserted-by":"publisher","first-page":"131","DOI":"10.18632\/oncoscience.119","volume":"2","author":"E Mart\u00ednez-Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez-Mart\u00ednez E, G\u00f3mez I, Mart\u00edn P, S\u00e1nchez A, Rom\u00e1n L, Tejerina E, et al. Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival. Oncoscience. 2015;2:131.","journal-title":"Oncoscience"},{"key":"3399_CR74","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","volume":"1812","author":"MJ Puppa","year":"2011","unstructured":"Puppa MJ, White JP, Sato S, Cairns M, Baynes JW, Carson JA. Gut barrier dysfunction in the ApcMin\/+ mouse model of colon cancer cachexia. Biochim Biophys Acta Mol Basis Dis. 2011;1812:1601\u20136.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3399_CR75","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1182\/blood-2009-11-251728","volume":"115","author":"SW Lane","year":"2010","unstructured":"Lane SW, Sykes SM, Al-Shahrour F, Shterental S, Paktinat M, Lo Celso C, et al. The Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD\/MDS. Blood. 2010;115:3489\u201397.","journal-title":"Blood"},{"key":"3399_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2613.2006.00477.x","volume":"87","author":"S You","year":"2006","unstructured":"You S, Ohmori M, Pe\u00f1a MMO, Nassri B, Quiton J, Al-Assad ZA, et al. Developmental abnormalities in multiple proliferative tissues of ApcMin\/+ mice. Int J Exp Pathol. 2006;87:227\u201336.","journal-title":"Int J Exp Pathol"},{"key":"3399_CR77","doi-asserted-by":"publisher","first-page":"997115","DOI":"10.3389\/fimmu.2022.997115","volume":"13","author":"A Sarsembayeva","year":"2023","unstructured":"Sarsembayeva A, Kienzl M, Gruden E, Ristic D, Maitz K, Valadez-Cosmes P, et al. Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells. Front Immunol. 2023;13:997115.","journal-title":"Front Immunol"},{"key":"3399_CR78","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood-2002-01-0098","volume":"100","author":"RJ McKallip","year":"2002","unstructured":"McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, et al. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002;100:627\u201334.","journal-title":"Blood"},{"key":"3399_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-019-0241-1","volume":"14","author":"M Rao","year":"2019","unstructured":"Rao M, Chen D, Zhan P, Jiang J. MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway. Biol Direct. 2019;14:1\u201313.","journal-title":"Biol Direct"},{"key":"3399_CR80","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S1462399409000957","volume":"11","author":"GA Cabral","year":"2009","unstructured":"Cabral GA, Griffin-Thomas L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med. 2009;11:e3.","journal-title":"Expert Rev Mol Med"},{"key":"3399_CR81","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00705-021-05223-7","volume":"166","author":"M Rastegar","year":"2021","unstructured":"Rastegar M, Samadizadeh S, Yasaghi M, Moradi A, Tabarraei A, Salimi V, et al. Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking. Arch Virol. 2021;166:3117\u201326.","journal-title":"Arch Virol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03399-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:22:30Z","timestamp":1757168550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03399-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":81,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025,8,4]]}},"alternative-id":["3399"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03399-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were conducted in accordance with the guidelines and with the approval of the Tel Aviv University Animal Care and Use Committee (Protocols 01-18-059, 01-18-060, and 01-21-010). All analyses of human data were performed in accordance with the guidelines and regulations of Tel Aviv University. Ethical approval for access to genomic data was obtained through the UKBiobank under application no. 86101 and through Tel Aviv University (approval number 0002372-1). The UKBiobank obtained written informed consent from all participants, as outlined in the UK Biobank ethics framework ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}